PeptidePedia The community reference

Information for SURPASS trial programme

Page information·measured at build time

Technical and provenance information about SURPASS trial programme. All figures on this page are measured from the emitted page rather than declared.

Basic information

Display titleSURPASS trial programme
Default sort keySURPASS trial programme
NamespaceArticle (main)
Page kindConcept
Page length (source, bytes)5,078
Rendered word count593
Internal wiki links on the page17
Defined citations4
Top-level sections3
Subsections0
Tables1
Figures0
InfoboxYes — concept
Maintenance bannersNone
Indexing by robotsAllowed

Edit history

Page creatorDataTableDunja
Date of page creation21 July 2024
Latest editorCiteBot
Date of latest edit16 July 2026
Total number of edits35
Total number of distinct authors28
Minor edits12
Automated (bot) edits3
Recent number of edits (last 90 days)3
Talk page posts4

Principal authors

EditorEditsShareDeclared focus
DataTableDunja38.6%clinical trials and evidence appraisal
EndpointEnid25.7%clinical trials and evidence appraisal
TrialsTabitha25.7%clinical trials and evidence appraisal
CiteBot25.7%copy-editing and the manual of style
AppendixAlva25.7%clinical trials and evidence appraisal
SurrogateSunday25.7%clinical trials and evidence appraisal
ArchiveAudit12.9%policy, notability and deletion
MelanocortinMil12.9%research peptides
LOD_Lorcan12.9%analytical chemistry and chromatography
CagriCass12.9%GLP-1 receptor agonists and related compounds
PioneerPerdita12.9%clinical trials and evidence appraisal
TriumphThad12.9%clinical trials and evidence appraisal

Category membership